1.
Lamkin EN, Shimony S, Mehra S, Lane A, Taylor J. Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines. Haematologica [Internet]. 2026Aug.27 [cited 2026Nov.5];. Available from: https://haematologica.org/article/view/14376